|
P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action
|
journal
|
February 2012 |
|
A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria
|
journal
|
February 2021 |
|
Synthesis of amino heterocycle aspartyl protease inhibitors
|
journal
|
January 2016 |
|
Species Differences in Distribution and Prediction of Human Vss from Preclinical Data
|
journal
|
August 2011 |
|
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
|
journal
|
November 2016 |
|
Retinal Toxicity Induced by a Novel β-secretase Inhibitor in the Sprague-Dawley Rat
|
journal
|
October 2014 |
|
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials
|
journal
|
August 2021 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
The cellular and molecular basis for malaria parasite invasion of the human red blood cell
|
journal
|
September 2012 |
|
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
|
journal
|
July 2015 |
|
An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS
|
journal
|
August 2011 |
|
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation
|
journal
|
December 2009 |
|
Quantitative measurement of Plasmodium -infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence
|
journal
|
March 2009 |
|
A dual target of Plasmepsin IX and X: Unveiling the atomistic superiority of a core chemical scaffold in malaria therapy
|
journal
|
November 2018 |
|
Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity
|
journal
|
July 2020 |
|
Subtle Changes in Endochin-Like Quinolone Structure Alter the Site of Inhibition within the Cytochrome bc 1 Complex of Plasmodium falciparum
|
journal
|
January 2015 |
|
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models
|
journal
|
March 2007 |
|
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
|
journal
|
August 2017 |
|
Thousands of chemical starting points for antimalarial lead identification
|
journal
|
May 2010 |
|
Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
|
journal
|
May 2018 |
|
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
|
journal
|
July 2020 |
|
Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness
|
journal
|
July 2021 |
|
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax
|
journal
|
July 2022 |
|
Structural Insights Into Key Plasmodium Proteases as Therapeutic Drug Targets
|
journal
|
March 2019 |
|
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
|
journal
|
August 2018 |
|
Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria
|
journal
|
September 2020 |
|
Long-term live imaging reveals cytosolic immune responses of host hepatocytes againstPlasmodiuminfection and parasite escape mechanisms
|
journal
|
September 2015 |
|
A multifunctional serine protease primes the malaria parasite for red blood cell invasion
|
journal
|
February 2009 |
|
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
|
journal
|
November 2012 |
|
Egress and invasion machinery of malaria: an in-depth look into the structural and functional features of the flap dynamics of plasmepsin IX and X
|
journal
|
January 2018 |
|
Transport mechanisms at the malaria parasite-host cell interface
|
journal
|
April 2021 |
|
Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations
|
journal
|
December 2011 |
|
Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme
|
journal
|
February 2022 |
|
PHENIX : building new software for automated crystallographic structure determination
|
journal
|
October 2002 |
|
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle
|
journal
|
April 2020 |
|
Malaria parasite plasmepsins: More than just plain old degradative pepsins
|
journal
|
June 2020 |
|
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
|
journal
|
April 2017 |
|
Rate- and Extent-Limiting Factors of Oral Drug Absorption: Theory and Applications
|
journal
|
September 2015 |
|
β‐Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
|
journal
|
August 2012 |
|
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
|
journal
|
December 2011 |
|
New developments in anti-malarial target candidate and product profiles
|
journal
|
January 2017 |
|
Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
|
journal
|
October 2016 |
|
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present)
|
journal
|
January 2020 |
|
Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond
|
journal
|
May 2012 |
|
A novel multiple-stage antimalarial agent that inhibits protein synthesis
|
journal
|
June 2015 |
|
Evaluation of Aminohydantoins as a Novel Class of Antimalarial Agents
|
journal
|
December 2013 |
|
The Development Process for Discovery and Clinical Advancement of Modern Antimalarials
|
journal
|
August 2019 |
|
The Corrected Traditional Equations for Calculation of Hepatic Clearance that Account for the Difference in Drug Ionization in Extracellular and Intracellular Tissue Water and the Corresponding Corrected PBPK Equation
|
journal
|
March 2011 |
|
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
|
journal
|
May 2007 |
|
A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress
|
journal
|
October 2017 |
|
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
|
journal
|
May 2008 |
|
BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease
|
journal
|
January 2014 |
|
Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion
|
journal
|
October 2017 |
|
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay
|
journal
|
January 2019 |
|
Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases
|
journal
|
March 2018 |
|
Proteases in Malaria Parasites - A Phylogenomic Perspective
|
journal
|
September 2011 |
|
A framework for assessing the risk of resistance for anti-malarials in development
|
journal
|
August 2012 |
|
Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set
|
journal
|
August 2016 |
|
Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2R null Mice Engrafted with Human Erythrocytes
|
journal
|
July 2009 |
|
Pushing the boundaries of molecular replacement with maximum likelihood
|
journal
|
September 2001 |
|
Cellular thermal shift assay for the identification of drug–target interactions in the Plasmodium falciparum proteome
|
journal
|
April 2020 |
|
A druggable secretory protein maturase of Toxoplasma essential for invasion and egress
|
journal
|
September 2017 |